Antipsychotic-induced weight gain and therapeutic response: a differential association.
about
Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problemsClozapine versus other atypical antipsychotics for schizophreniaOlanzapine versus other atypical antipsychotics for schizophreniaMetabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the MythsAcute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophreniaSignificant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subjectGilles de la Tourette syndrome: the complexities of phenotype and treatmentAntipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks.Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patientsGenetics of antipsychotic treatment emergent weight gain in schizophrenia.Predictors of switching antipsychotic medications in the treatment of schizophreniaPsychotropic medication use mediates the relationship between mood and anxiety disorders and obesity: findings from a nationally representative sample.Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity.Almost all antipsychotics result in weight gain: a meta-analysis.Weight gain profiles of new anti-psychotics: public health consequences.Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatmentAntipsychotic-induced weight gain.Atypical antipsychotics in psychiatric practice: practical implications for clinical monitoring.A Longitudinal Study of Relation between Side-effects and Clinical Improvement in Schizophrenia: Is There a Neuro-metabolic Threshold for Second Generation Antipsychotics?Body mass index and blood glucose in psychiatric and general practice populationsThe association between weight change and symptom reduction in the CATIE schizophrenia trial.Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.Factors associated with response to clozapine in schizophrenia: a review.Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.Lipid effects of psychiatric medications.Haloperidol for long-term aggression in psychosis.Atypical antipsychotics cause an acute increase in cutaneous hand blood flow in patients with schizophrenia and schizoaffective disorder.Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia.[Efficacy of behavioural lifestyle interventions for weight management of psychiatric patients].Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.Accuracy of body image perception and preferred weight loss strategies in schizophrenia: a controlled pilot study.Long-acting risperidone in stable patients with schizoaffective disorder.Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic.The 'boon and bane' of antipsychotic-induced metabolic syndrome.The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia.Is there an interrelationship between the effects of antipsychotics on psychopathology and on metabolism?Creation of a metabolic monitoring program for second-generation (atypical) antipsychotics.Metabolic Syndrome Prevalence and Reduction in Inmates Prescribed Antipsychotic Medications.
P2860
Q24235450-023DC664-C494-4CCD-A628-F402D64F17B4Q24236422-7B473BAD-25F8-4571-A404-547DCFB15027Q24236545-BEE69705-6B5E-42A4-8975-17383C7FC212Q24596954-2D0C0285-6C99-410B-A0BC-39D0304EAC2BQ24798487-C3C91C6B-4391-4FCC-9728-477436689BADQ28073082-659F4F64-BBD2-40A1-B460-A725CE6F26D7Q28306632-4FBFE645-E2E3-41B9-97B9-D43440416F84Q30370326-6B3D9BEA-615E-4BFA-9D63-20B6CDFC9FE6Q30511886-BE5C7B74-1AFE-4385-B23E-0423D66D2213Q33257886-564B8CC2-3F9E-4A68-BAC7-A18593600F36Q33709704-2F533F11-0F30-46F3-88AD-A6D57BBC42E9Q34049910-A6EC837B-3A9C-49B9-8CC4-9EA82CCF2BB3Q34228522-66F2554E-3442-4BA9-B9E0-9F1FD430FD1FQ34661499-120C2FC1-5962-4E63-AA2A-54DA55F6727EQ35198895-5879D546-CF45-4D53-8A11-67D055B5DC28Q35968139-549F99D9-DA75-4989-B59C-E4A83E8A3196Q36211002-B47A8554-7BCD-4E08-8D52-455E9598C3ACQ36302677-E655492E-1A25-4DD6-A27A-13D5EBC8CA8FQ36832340-467E5C84-A7E3-455B-A5AC-716A28F5FDA0Q36953215-2C38FBC0-E979-4435-9387-EBEB9EE1097FQ37212106-F68A5F7E-303B-4732-82F4-F4D0081D67EFQ37244634-85E526FC-80D6-4EE7-8824-660233DFED89Q37300007-B7A609FC-E291-4C3A-B8BA-C68FAB32F7C2Q37865505-3F173BBE-1E88-46EB-8F64-4DB3A536CD9AQ38042478-DE88E2C9-20BA-4273-A633-0F0EFCCEA18FQ38066118-80088464-21AE-4FC6-A341-E39AA754EA1DQ39021131-5E1D9429-9E13-4D55-8C43-CC801570583EQ39713953-84DD8E9A-7197-4C2A-89A1-421666ECB8CCQ42433433-38FC743A-9CE1-4AB5-BEF4-336D71819C96Q45209540-46D5D0C1-3A31-48B2-A51B-CFCCECA0582AQ45257719-A8ABE406-4B7A-4E07-9240-E1D9828033A2Q45938197-1B0977D2-7F07-4ACE-A37B-E29FB284277AQ46689239-F6619294-BDC6-48C3-B28F-A95624F3DF72Q46798701-982967D1-AB2C-42D1-8DC7-FC58094D363AQ47671257-A4538FDC-B755-411D-81DF-A8B11008441AQ49481418-FFDAD22F-534C-4CC0-8C15-96AA9C210434Q50601108-7389B3CF-6293-40DE-88D1-8641BF3E74EEQ50973671-A3D7EF1E-A610-49F8-87EF-BD24A54D4B13Q51818927-F86486BD-0AB2-4FD8-9FA1-A2B5FE1678EDQ53509978-A22839EF-C7E5-436C-9221-9FB55895AF24
P2860
Antipsychotic-induced weight gain and therapeutic response: a differential association.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Antipsychotic-induced weight gain and therapeutic response: a differential association.
@en
Antipsychotic-induced weight gain and therapeutic response: a differential association.
@nl
type
label
Antipsychotic-induced weight gain and therapeutic response: a differential association.
@en
Antipsychotic-induced weight gain and therapeutic response: a differential association.
@nl
prefLabel
Antipsychotic-induced weight gain and therapeutic response: a differential association.
@en
Antipsychotic-induced weight gain and therapeutic response: a differential association.
@nl
P2093
P50
P1476
Antipsychotic-induced weight gain and therapeutic response: a differential association
@en
P2093
Brian Sheitman
Jean-Pierre Lindenmayer
Joseph McEvoy
Miranda Chakos
Pál Czobor
Thomas B Cooper
P304
P356
10.1097/00004714-200206000-00003
P407
P577
2002-06-01T00:00:00Z